Wednesday, October 19, 2011: 8:30 AM
Symphony III (Hilton Minneapolis)
This section focuses on the use of Process Analytical Technologies to monitor, control, and gain a better understanding of Pharmaceutical manufacturing processes at commercial scales (drug products and drug substances (APIs)). Authors are encouraged to submit papers discussing case studies, research, and value-added applications of PAT in manufacturing settings as well as challenges overcome and lessons learned while implementing PAT in pharmaceutical manufacturing operations.
Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture
Mark A. LaPack
- indicates paper has an Extended Abstract file available on CD.
See more of this Group/Topical: Topical I: Comprehensive Quality by Design in Pharmaceutical Development and Manufacture